Skip to main content
Premium Trial:

Request an Annual Quote

Lentigen, Dharmacon, Qiagen, Sigma-Aldrich

Lentigen and Dharmacon have recently introduced Smartvector shRNA lentiviral particles, which combine Dharmacon’s gene-silencing reagents with Lentigen’s LentiMax lentiviral vector technology.
According to the companies, the particles are capable of expressing highly functional shRNA that efficiently and stably silences gene expression in a wide variety of cells.  

Qiagen recently announced that its HP validated siRNAs will be provided with full sequence information at no additional cost.
According to the company, the full sequence information provides data for analysis of experimental results and verification of knockdown.

Sigma-Aldrich has launched the LentiExpress shRNA-based system, which is designed to allow rapid high-throughput RNAi screening with minimal reagent preparation or optimization.
According to the company, the system consists of pre-arrayed lentiviral particles harboring shRNAs from the RNAi Consortium collection.
The system is currently available with the RNAi Consortium’s human kinase shRNA collection, and includes 3,109 individual pre-arrayed lentiviral clones harboring shRNA sequences that target 673 human kinase genes for gene silencing.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.